JOHN VIERLING to Chemical and Drug Induced Liver Injury
This is a "connection" page, showing publications JOHN VIERLING has written about Chemical and Drug Induced Liver Injury.
Connection Strength
1.191
-
HIV infection and the liver: the importance of HCV-HIV coinfection and drug-induced liver injury. Clin Liver Dis. 2011 Feb; 15(1):131-52.
Score: 0.296
-
Liver Biopsy Features May Help Distinguish Drug-Induced Autoimmune-Like Hepatitis From Idiopathic Autoimmune Hepatitis. Arch Pathol Lab Med. 2026 Jan 14; 150(6):448-456.
Score: 0.209
-
Nomenclature, diagnosis and management of drug-induced autoimmune-like hepatitis (DI-ALH): An expert opinion meeting report. J Hepatol. 2023 09; 79(3):853-866.
Score: 0.173
-
Best practices for detection, assessment and management of suspected immune-mediated liver injury caused by immune checkpoint inhibitors during drug development. J Autoimmun. 2020 11; 114:102514.
Score: 0.143
-
Acute hepatitis associated with the Chinese herbal product jin bu huan. Ann Intern Med. 1994 Nov 15; 121(10):729-35.
Score: 0.096
-
Genetics of drug-induced hepatotoxicity toxicity in Gilbert's syndrome. Am J Gastroenterol. 2013 Dec; 108(12):1936-7.
Score: 0.090
-
Imatinib (Gleevec)-induced hepatotoxicity. J Clin Gastroenterol. 2005 Jan; 39(1):75-7.
Score: 0.049
-
Early hepatic nodular hyperplasia and submicroscopic fibrosis associated with 6-thioguanine therapy in inflammatory bowel disease. Am J Surg Pathol. 2004 Sep; 28(9):1204-11.
Score: 0.047
-
Limited role for CXC chemokines in the pathogenesis of alpha-naphthylisothiocyanate-induced liver injury. Am J Physiol Gastrointest Liver Physiol. 2004 Sep; 287(3):G734-41.
Score: 0.046
-
Hepatic injury by prescription medication. Med Sect Proc. 1983; 79-86.
Score: 0.042